Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 82-1206912 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The Ketamine Research Foundation's mission is the development of Ketamine's use for psychiatric and psychotherapeutic science and clinical practice, Research, education, and training.
Principal Officer
Philip E Wolfson MD
Total Revenue
$674K
FY2024
Total Expenses
$641K
FY2024
Net Assets
$559K
Program Ratio
93.9%
expenses on programs
Employees
0
Volunteers
0
Board Members
6
Voting
6
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.